SCHEMBL8714095

SCHEMBL8714095

C=C1SC(=S)N(c2ccc(-c3ccccc3)cc2)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.47
MGLL Q99685 1/20 0.47
DUSP22 Q9NRW4 4/20 0.44
DUSP3 P51452 1/20 0.44
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
MAPT P10636 6/20 0.42
ALDH1A1 P00352 5/20 0.42
POLB P06746 2/20 0.42
THRB P10828 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPK1 P28482 1/20 0.42
PTPN1 P18031 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
PDE6D O43924 1/20 0.40
CDC25A P30304 1/20 0.40
CDC25B P30305 1/20 0.40
CDC25C P30307 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10134069 0.90 MEN1 (0.51) MGLLDUSP22DUSP3MEN1KMT2A
SCHEMBL10165555 0.80 HSPD1 (0.51) MGLLDUSP22DUSP3MEN1KMT2A
SCHEMBL24487207 0.80 KMT2A (0.56) MGLLDUSP22DUSP3MEN1KMT2A
SCHEMBL13873081 0.80 KMT2A (0.50) MGLLDUSP22MEN1KMT2AMAPT
SCHEMBL8682649 0.79 FFAR1 (0.47) MEN1KMT2APOLBPTPN1MCL1
SCHEMBL8712071 0.78 MGLL (0.50) MGLLMEN1KMT2AMAPTALDH1A1
SCHEMBL8684983 0.78 BCL2 (0.48) DUSP22DUSP3MEN1KMT2APOLB
SCHEMBL8711576 0.76 MAPT (0.55) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL12081658 0.76 MAPT (0.54) MGLLDUSP22MEN1KMT2AMAPT
SCHEMBL10134091 0.76 DUSP22 (0.46) DUSP22DUSP3MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed